Scholars@Duke

AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness

Publication ,  Conference
Llanga, TA; Miyadera, K; Conatser, L; Gilger, B; Kurtzberg, J; Samulski, RJ; Hirsch, M
Published in: MOLECULAR THERAPY
April 22, 2019
Link to item

Duke Scholars

Joanne Kurtzberg
Author Joanne Kurtzberg Pediatrics, Transplant and Cellular Therapy

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

441 / 442

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Llanga, T. A., Miyadera, K., Conatser, L., Gilger, B., Kurtzberg, J., Samulski, R. J., & Hirsch, M. (2019). AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness. In MOLECULAR THERAPY (Vol. 27, pp. 441–442). Washington, DC: CELL PRESS.
Llanga, Telmo A., Keiko Miyadera, Laura Conatser, Brian Gilger, Joanne Kurtzberg, Richard J. Samulski, and Matthew Hirsch. “AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness.” In MOLECULAR THERAPY, 27:441–42. CELL PRESS, 2019.
Llanga TA, Miyadera K, Conatser L, Gilger B, Kurtzberg J, Samulski RJ, et al. AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 441–2.
Llanga, Telmo A., et al. “AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness.” MOLECULAR THERAPY, vol. 27, no. 4, CELL PRESS, 2019, pp. 441–42.
Llanga TA, Miyadera K, Conatser L, Gilger B, Kurtzberg J, Samulski RJ, Hirsch M. AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness. MOLECULAR THERAPY. CELL PRESS; 2019. p. 441–442.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

441 / 442

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences